Citation Tools
PDFCurrent controversy
CRISPR immunity: a case study for justified somatic genetic modification?
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- CRISPR immunity: a case study for justified somatic genetic modification?
Other content recommended for you
- Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy
- Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study
- SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
- COVID-19 and liver disease
- Ethics of genomic passports: should the genetically resistant be exempted from lockdowns and quarantines?
- Risk of COVID-19 re-infection and its predictors (CORES): protocol for a community-based longitudinal cohort study in Vellore, India
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
- Why ‘one size fits all’ is not enough when designing COVID-19 immunity certificates for domestic use: a UK-wide cross-sectional online survey
- Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients
- COVID-19 vaccine hesitancy and vaccine passports: a cross-sectional conjoint experiment in Japan